Pharmaco-Economicbenefits of Correction of Anemia With Continuous Erythropoietin Receptor Activator:hemodialysis Vshemodiafiltration
Ukrainian Journal of Nephrology and Dialysis
doi 10.31450/ukrjnd.1(53).2017.04
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2017
Authors
Publisher
Institute of Nephrology of the National Academy of Medical Sciences